Skip to main content
Clinical Trials/NL-OMON49224
NL-OMON49224
Completed
Not Applicable

The Personalized Parkinson Project - de novo cohort - PPP NOVO

Radboud Universitair Medisch Centrum0 sites144 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson's Disease
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
144
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Prior to enrollment in this clinical investigation, candidates must meet ALL of
  • the following criteria:
  • \* Subject has never been treated before with any symptomatic dopaminergic drug
  • treatment for Parkinson\*s disease and is not expected to start treatment for
  • motor symptoms of PD within 52 weeks from baseline.
  • \* Subject has Parkinson\*s disease of \<\=2 years of duration, defined as the time
  • since the diagnosis was made by a neurologist.
  • \* Subject is an adult, at least 18 years of age.
  • \* Subject can read and understand Dutch.
  • \* Subject has completed the CMO\-approved Informed Consent.

Exclusion Criteria

  • Candidates must be excluded from this study if ANY of the following criteria
  • \* Subject is pregnant or breastfeeding.
  • \* Subject has co\-morbidities that would hamper interpretation of
  • parkinsonian disability, such as coincident musculoskeletal abnormalities, in
  • the opinion of the lnvestigator.
  • \* Subject is allergic to nickel.

Outcomes

Primary Outcomes

Not specified

Similar Trials